Eli Lilly & Co. (LLY:US): The Indianapolis-based drugmaker won approval from the U.S. Food and Drug Administration to broaden use of its top-selling antipsychotic medicine, Zyprexa, to teenagers with schizophrenia or bipolar disorder.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.